ORIGINAL RESEARCH—PHARMACOTHERAPY: Efficacy of Sildenafil Citrate in Men with Erectile Dysfunction Following Radical Prostatectomy: A Systematic Review of Clinical Data
- 1 September 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 2 (5) , 658-667
- https://doi.org/10.1111/j.1743-6109.2005.00117.x
Abstract
Radical prostatectomy is a frequently used treatment option for prostate cancer; however, prostatectomy is often associated with significant morbidity, including erectile dysfunction (ED). To analyze the efficacy of sildenafil citrate in treating ED after radical prostatectomy. MEDLINE and CANCERLIT (1998 to January 2004) were searched for English language articles using the key words prostatectomy, sildenafil, and phosphodiesterase inhibitors. Eleven studies fulfilled the inclusion criteria: primary, discrete data sets of postprostatectomy patients with ED treated with sildenafil monotherapy. Sample sizes ranged from 13 to 198 (mean age, 61 ± 3 years). Treatment durations were 4 weeks (or more than four doses) to 1 year, and sildenafil dosing was in the recommended range (25–100 mg). Seven studies reported a response rate (range, 14%−53%) for an end point consistent with the primary analysis outcome (erection sufficient for vaginal intercourse); the combined estimate of probability of response was 35% (95% confidence interval [CI], 24%−48%). There was strong evidence for a lower response rate after non–nerve‐sparing (range, 0%−15%) versus nerve‐sparing surgery (range, 35%−75%; combined odds ratio [OR] = 12.1; 95% CI, 5.5–26.6) but not after unilateral (range, 10%−80%) versus bilateral nerve‐sparing surgery (range, 46%−72%; combined OR = 2.21; 95% CI, 0.75–6.54). The results of these studies demonstrate that with sildenafil, more than one third of patients with postprostatectomy ED achieved erection sufficient for intercourse. The odds of responding improved 12‐fold with preservation of at least one neurovascular bundle. Early treatment failure does not necessarily imply lack of efficacy in the future, and patients should be encouraged to continue trying sildenafil, titrating up to 100 mg as needed. Montorsi F, and McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005;2:658–667.Keywords
This publication has 43 references indexed in Scilit:
- PREVENTION AND MANAGEMENT OF ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMYPublished by Elsevier ,2005
- Meta-analysis of rates of erectile function after treatment of localized prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Treatment outcomes in localized prostate cancer: a patient-oriented approach.Seminars in Urologic Oncology, 2002
- Management of erectile dysfunction following radical prostatectomyCurrent Urology Reports, 2001
- FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMYJournal of Urology, 2000
- Erectile DysfunctionNew England Journal of Medicine, 2000
- Return of Erections and Urinary Continence Following Nerve Sparing Radical Retropubic ProstatectomyJournal of Urology, 1993
- Sexual Function following Radical Prostatectomy: Influence of Preservation of Neurovascular BundlesJournal of Urology, 1991
- Detailed Anatomy of Penile Neurovascular Structures: Surgical SignificanceJournal of Urology, 1989
- Radical Prostatectomy, Preservation of Sexual Function, Cancer ControlUrologic Clinics of North America, 1987